A postdoctoral fellow from the RI-MUHC is recognized for international work on TB diagnostics

A $109M fund aims to mitigate impact of the pandemic on care delivery in Canada and beyond, as well as contribute to better understanding of the disease

In two recent studies, RI-MUHC researchers provide useful information for evaluating public health strategies

A new study shows that rifampin regimen is cheaper than isoniazid for latent tuberculosis

RI-MUHC researcher Abhinav Sharma calls for an approach emphasizing voluntary consent

RI-MUHC research team, Emily McDonald and Todd C. Lee, ties for Marika Zelenka Roy Innovation Prize

A new study highlights a strong risk factor for COPD related to lung development

Congratulations to Joseph Mussa!

A new study suggests that hydroxychloroquine is not effective in preventing the development of COVID-19 in individuals exposed to SARS-CoV-2

RI-MUHC researchers awarded MUHC Foundation funding for a second round of projects with potential impact in a short timeframe

Christina Wolfson is co-principal investigator on a new national study

Congratulations to Marina Machado!

Study published in the Annals of Internal Medicine

RI-MUHC researchers awarded MUHC Foundation funding for projects with potential impact in a short timeframe

Initially restricted to health care workers in Quebec, the clinical study is now open to all eligible adults

Dr. Madhukar Pai explains why TB services might be one of the biggest casualties of the pandemic

Epidemiologist who conducted some of the first Canadian studies in colorectal cancer screening has a talent for outreach

David Buckeridge is one of 47 Canadian researchers chosen to contribute to the global response

Dr. Nitika Pant Pai speaks out on global microbial threats

The award-winning MIPOGG app garners more international support